An integrated genomics and metabolomics approach for defining survival time in adult oligodendrogliomas patients.
- Contribuables: C Bund, M Guergova-Kuras, AE Cicek, FM Moussallieh, N Dali-Youcef, M Piotto, P Schneider, N Entz-Werle, B Lhermitte, MP Chenard, R Schott, F Proust, G Noël, IJ Namer
Metabolomics 15:69, 2019.
161_HRMAS_Oligo3